Fort Lauderdale, FL – According to filings with the U.S. Securities and Exchange Commission, Psycheceutical is raising $2,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Chad Harman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Psycheceutical
At Psycheceutical we employ next-generation patented Janus particles and novel delivery technologies to bring safety and efficacy to psychedelic compounds for the medical and pharmaceutical industries. These advanced delivery systems allow for safe dosage control and consistent desired results. We have over 100 years of combined experience in development, regulatory approval process, and commercialization. Our visionary founders are considered among the top minds in the psychedelic space.

To learn more about Psycheceutical, visit http://psycheceutical.com/

Contact:
Chad Harman, Chief Executive Officer
303-507-5538
https://www.linkedin.com/in/chad-harman-a287b7137/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved